Galactosylation does not prevent the rapid clearance of long-term, 4 °C-stored platelets

Blood

Volumn 111, Issue 6, 2008, Pages 3249-3256

  Wandall, Hans H ^a,c   Hoffmeister, Karin M ^b   Sørensen, Anne Louise ^a,c   Rumjantseva, Viktoria ^b   Clausen, Henrik ^a,c   Hartwig, John H ^b   Slichter, Sherrill J ^d,e  

^a ZymeQuest Inc   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URIDINE DIPHOSPHATE GALACTOSE; GALACTOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; APHERESIS; ARTICLE; CELL SURVIVAL; CLEARANCE; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE PRESERVATION; ANIMAL; BLOOD STORAGE; C57BL MOUSE; COLD; CYTOLOGY; DRUG EFFECT; METABOLISM; METHODOLOGY; THROMBOCYTE TRANSFUSION; TIME;

ANIMALS; BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; BLOOD PRESERVATION; CELL SURVIVAL; COLD; FEMALE; GALACTOSE; HUMANS; MALE; MICE; MICE, INBRED C57BL; PLATELET TRANSFUSION; TIME FACTORS; URIDINE DIPHOSPHATE GALACTOSE;

EID: 42449087743     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-06-097295     Document Type: Article

References (36)

1. Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability: deleterious effect of refrigerated storage. N Engl J Med. 1969;280: 1094-1098.
2. Slichter SJ, Harker LA. Preparation and storage of platelet concentrates. II: storage variables influencing platelet viability and function. Br J Haematol. 1976;34:403-419.
3. Gottschall JL, Rzad L, Aster RH. Studies of the minimum temperature at which human platelets can be stored with full maintenance of viability. Transfusion. 1986;26:460-462.
4. Dumont LJ, VandenBroeke T. Ault KA. Platelet surface P-selectin measurements in platelet preparations: an international collaborative study. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT). Transfus Med Rev. 1999;13:31-42.
5. Michelson AD, Adelman B, Barnard MR, Carroll E, Handin Rl. Platelet storage results in a redistribution of glycoprotein lb molecules: evidence for a large intraplatelet pool of glycoprotein lb. J Clin Invest. 1988;81:1734-1740.
6. Ribeiro A, Swann JC, Berndt MC. Alterations of the levels of glycoproteins Ib-lX and IIb-IIIa in platelets stored at 22 degrees C. Thromb Res. 1992;66:619-627.
7. Jaremo P, Rubach-Dahlberg E, Solum NO. Correlation of light transmission changes to changes of platelet glycoprotein Ib during storage of platelet concentrates. Thromb Res. 1993;69:467-477.
8. Hoffmeister KM, Felbinger TW, Falet H, etal. The clearance mechanism of chilled blood platelets. Cell. 2003;112:87-97.
9. Valeri CR, Ragno G, Marks PW, et al. Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(beta-aminoethyl ether) N. N'-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4 degrees C for as long as 5 days. Transfusion. 2004;44:865-870.
10. Hoffmeister KM, Josefsson EC, Isaac NA, et al. Glycosylation restores survival of chilled blood platelets. Science. 2003;301:1531-1534.
11. Babic AM, Josefsson EC, Bergmeier W, et al. In vitro function and phagocytosis of galactosylated platelet concentrates after long-term refrigeration. Transfusion. 2007;47:442-451.
12. Josefsson EC, Gebhard HH, StosselTP, Hartwig JH, Hoffmeister KM. The macrophage alphaM-beta2 integrin alphaM lectin domain mediates the phagocytosis of chilled platelets. J Biol Chem. 2005;280:18025-18032.
13. Holme S, Heaton A, Roodt J. Concurrent label method with 111 In and 51 Cr allows accurate evaluation of platelet viability of stored platelet concentrates. Br J Haematol. 1993;84:717-723.
14. Lotter MG, Rabe WL, Van Zyl JM, et al. A computer program in compiled BASIC for the IBM personal computer to calculate the mean platelet survival time with the multiple-hit and weighted mean methods. Comput Biol Med. 1988;18:305-315.
15. Kunicki TJ, Tuccelli M, Becker GA, Aster RH. A study of variables affecting the quality of platelets stored at "room temperature". Transfusion. 1975; 15:414-421.
16. Murphy S, Rebulla P, Bertolini F, et al. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion. Transfus Med Rev. 1994;8:29-36.
17. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1996.
18. Coxon A, Rieu P, Barkalow FJ, et al. A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 1996;5:653-666.
19. Baker GR, Sullam PM, Levin J. A simple, fluorescent method to internally label platelets suitable for physiological measurements. Am J Hematol. 1997;56:17-25.
20. McGill M. Temperature cycling preserves platelet shape and enhances in vitro test scores during storage at 4 degrees. J Lab Clin Med. 1978;92:971-982.
21. Reimers HJ, Greenberg J, Cazenave JP, Packham MA, Mustard JF. Experimental modification of platelet survival. Adv Exp Med Biol. 1977;82: 231-233.
22. Wahrenbrock MG, Varki A. Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the "tip of the iceberg"? Cancer Res. 2006;66:2433-2441.
23. Steiner M, Vancura S. Asymmetrical loss of sialic acid from membrane glycoproteins during platelet aging. Thromb Res. 1985;40:465-471.
24. Greenberg J, Packham MA, Cazenave JP, Reimers HJ, Mustard JF. Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab Invest. 1975;32:476-484.
25. Kotze HF, van Wyck V, Badenhorst PN, et al. Influence of platelet membrane sialic acid and platelet-associated IgG on ageing and sequestration of blood platelets in baboons. Thromb Haemost. 1993;70:676-680.
26. Ellies LG, Ditto D, Levy GG, et al. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci U SA. 2002;99:10042-10047.
27. Tribulatti MV, Mucci J, Van RN, Leguizamon MS, Campetella O. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents. Infect Immun. 2005;73:201-207.
28. Inyang AL, Sodeinde O, Okpako DT, Essien EM. Platelet reactions after interaction with cultured Plasmodium falciparum infected erythrocytes. Br J Haematol. 1987;66:375-378.
29. Inyang AL, Okpako D, Essien EM. Decrease in platelet survival and total platelet sialic acid concentration in rats infected with Plasmodium bergei bergei. Afr J Med Med Sci. 1995;24:41-46.
30. Badlou BA, Ijseldijk MJ, Smid WM, Akkerman JW. Prolonged platelet preservation by transient metabolic suppression. Transfusion. 2005;45:214-222.
31. Gousset K, Wolkers WF, Tsvetkova NM, et al. Evidence for a physiological role for membrane rafts in human platelets. J Cell Physiol. 2002;190:117-128.
32. Gousset K, Tsvetkova NM, Crowe JH, Tablin F. Important role of raft aggregation in the signaling events of cold-induced platelet activation. Biochim Biophys Acta. 2004;1660:7-15.
33. Tablin F, Wolkers WF, Walker NJ, et al. Membrane reorganization during chilling: implications for long-term stabilization of platelets. Cryobiology. 2001;43:114-123.
34. Boylan B, Berndt MC, Kahn ML. Newman PJ. Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. Blood. 2006;108:908-914.
35. Ishikawa F, Yasukawa M, Lyons B, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain-(null) mice. Blood. 2005;106:1565-1573.
36. Macchiarini F, Manz MG, Palucka AK, Shultz LD. Humanized mice: are we there yet? J Exp Med. 2005;202:1307-1311.